Effects of oral ingestion of sucralose on gut hormone response and appetite in healthy normal-weight subjects

European Journal of Clinical Nutrition

Volumn 65, Issue 4, 2011, Pages 508-513

  Ford, H E ^a   Peters, V ^a   Martin, N M ^a   Sleeth, M L ^a   Ghatei, M A ^a   Frost, G S ^a   Bloom, S R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

appetite; gut hormone; obesity; sucralose; sweetener

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLUCOSE POLYMER; INSULIN; MALTODEXTRIN; PEPTIDE YY; SPLENDA; SUCRALOSE; UNCLASSIFIED DRUG; WATER;

ADULT; APPETITE; ARTICLE; CALORIC INTAKE; CELL STIMULATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DRUG MECHANISM; ENTEROENDOCRINE CELL; FEMALE; FLUID INTAKE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SHAM FEEDING; SINGLE BLIND PROCEDURE;

ADULT; APPETITE; BLOOD GLUCOSE; CROSS-OVER STUDIES; ENERGY INTAKE; FEMALE; GASTROINTESTINAL HORMONES; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; MALE; PEPTIDE YY; SINGLE-BLIND METHOD; SUCROSE; SWEETENING AGENTS; YOUNG ADULT;

EID: 79953773104     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2010.291     Document Type: Article

References (41)

1. Abdallah L, Chabert M, Louis-Sylvestre J (1997). Cephalic phase responses to sweet taste. Am J Clin Nutr 65, 737-743. (Pubitemid 27111079)
2. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR (1985). Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89, 1070-1077. (Pubitemid 16231572)
3. Ahren B, Holst JJ (2001). The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia. Diabetes 50, 1030-1038. (Pubitemid 32374533)
4. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL et al. (2002). Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418, 650-654.
5. Bray GA, Nielsen SJ, Popkin BM (2004). Consumption of highfructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79, 537-543. (Pubitemid 41103894)
6. Brown RJ, Walter M, Rother KI (2009). Ingestion of diet soda before a glucose load augments GLP-1 secretion. Diabetes Care 32, 2184-2186.
7. Challis BG, Pinnock SB, Coll AP, Carter RN, Dickson SL, O'rahilly S (2003). Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. Biochem Biophys Res Commun 311, 915-919. (Pubitemid 37393405)
8. Chelikani PK, Haver AC, Reeve Jr JR, Keire DA, Reidelberger RD (2006). Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats. Am J Physiol Regul Integr Comp Physiol 290, R298-R305.
9. Chelikani PK, Haver AC, Reidelberger RD (2005a). Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats. Endocrinology 146, 879-888. (Pubitemid 40129846)
10. Chelikani PK, Haver AC, Reidelberger RD (2005b). Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats. Am J Physiol Regul Integr Comp Physiol 288, R1695-R1706. (Pubitemid 40720720)
11. Christofides ND, Sarson DL, Albuquerque RH, Adrian TE, Ghatei MA, Modlin IM et al. (1979). Release of gastrointestinal hormones following an oral water load. Experientia 35, 1521-1523.
12. Degen L, Oesch S, Casanova M, Graf S, Ketterer S, Drewe J et al. (2005). Effect of peptide YY3-36 on food intake in humans. Gastroenterology 129, 1430-1436. (Pubitemid 41597385)
13. Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ (2002). Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 76, 911-922. (Pubitemid 35244659)
14. Elrick H, Stimmler L, Hlad Jr CJ, Rai Y (1964). Plasma insulin response to oral and intravenous glucose administration. J Clin Endocrinol Metab 24, 1076-1082.
15. Flint A, Raben A, Astrup A, Holst JJ (1998). Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101, 515-520. (Pubitemid 28084232)
16. Flint A, Raben A, Blundell JE, Astrup A (2000). Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 24, 38-48. (Pubitemid 30098877)
17. Fujita Y, Wideman RD, Speck M, Asadi A, King DS, Webber TD et al. (2009). Incretin release from gut is acutely enhanced by sugar but not by sweeteners in vivo. Am J Physiol Endocrinol Metab 296, E473-E479.
18. Ghatei MA, Uttenthal LO, Christofides ND, Bryant MG, Bloom SR (1983). Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract. J Clin Endocrinol Metab 57, 488-495. (Pubitemid 13005511)
19. Grice HC, Goldsmith LA (2000). Sucralose-an overview of the toxicity data. Food Chem Toxicol 38(Suppl 2), S1-S6.
20. Grotz VL, Henry RR, McGill JB, Prince MJ, Shamoon H, Trout JR et al. (2003). Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes. J Am Diet Assoc 103, 1607-1612.
21. Gutzwiller JP, Goke B, Drewe J, Hildebrand P, Ketterer S, Handschin D et al. (1999). Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 44, 81-86. (Pubitemid 29143284)
22. Halatchev IG, Ellacott KL, Fan W, Cone RD (2004). Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptorindependent mechanism. Endocrinology 145, 2585-2590. (Pubitemid 38686200)
23. Hall WL, Millward DJ, Rogers PJ, Morgan LM (2003). Physiological mechanisms mediating aspartame-induced satiety. Physiol Behav 78, 557-562. (Pubitemid 36628081)
24. Jang HJ, Kokrashvili Z, Theodorakis MJ, Carlson OD, Kim BJ, Zhou J et al. (2007). Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci USA 104, 15069-15074. (Pubitemid 47619594)
25. Kreymann B, Williams G, Ghatei MA, Bloom SR (1987). Glucagonlike peptide-1 7-36: a physiological incretin in man. Lancet 2, 1300-1304. (Pubitemid 17156636)
26. Le Roux CW, Batterham RL, Aylwin SJ, Patterson M, Borg CM, Wynne KJ et al. (2006). Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 147, 3-8. (Pubitemid 43004254)
27. Li X, Staszewski L, Xu H, Durick K, Zoller M, Adler E (2002). Human receptors for sweet and umami taste. Proc Natl Acad Sci USA 99, 4692-4696. (Pubitemid 34286046)
28. Luscombe-Marsh ND, Smeets AJ, Westerterp-Plantenga MS (2009). The addition of monosodium glutamate and inosine monophosphate-5 to high-protein meals: effects on satiety, and energy and macronutrient intakes. Br J Nutr 102, 929-937.
29. Ma J, Bellon M, Wishart JM, Young R, Blackshaw LA, Jones KL et al. (2009). Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects. Am J Physiol Gastrointest Liver Physiol 296, G735-G739.
30. Morgan JF, Reid F, Lacey JH (2000). The SCOFF questionnaire: a new screening tool for eating disorders. West J Med 172, 164-165.
31. Murphy KG, Bloom SR (2006). Gut hormones and the regulation of energy homeostasis. Nature 444, 854-859. (Pubitemid 46024992)
32. Nelson G, Hoon MA, Chandrashekar J, Zhang Y, Ryba NJ, Zuker CS (2001). Mammalian sweet taste receptors. Cell 106, 381-390. (Pubitemid 32772621)
33. Parker HE, Reimann F, Gribble FM (2010). Molecular mechanisms underlying nutrient-stimulated incretin secretion. Expert Rev Mol Med 12, e1.
34. Raben A, Vasilaras TH, Moller AC, Astrup A (2002). Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am J Clin Nutr 76, 721-729.
35. Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ, Gribble FM (2008). Glucose sensing in L cells: a primary cell study. Cell Metab 8, 532-539.
36. Rozengurt N, Wu SV, Chen MC, Huang C, Sternini C, Rozengurt E (2006). Colocalization of the alpha-subunit of gustducin with PYY and GLP-1 in L cells of human colon. Am J Physiol Gastrointest Liver Physiol 291, G792-G802. (Pubitemid 44772005)
37. Sutherland K, Young RL, Cooper NJ, Horowitz M, Blackshaw LA (2007). Phenotypic characterization of taste cells of the mouse small intestine. Am J Physiol Gastrointest Liver Physiol 292, G1420-G1428. (Pubitemid 47084658)
38. Talsania T, Anini Y, Siu S, Drucker DJ, Brubaker PL (2005). Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 146, 3748-3756. (Pubitemid 41175742)
39. Teff KL, Devine J, Engelman K (1995). Sweet taste: effect on cephalic phase insulin release in men. Physiol Behav 57, 1089-1095.
40. Van Strien T, Rookus MA, Bergers GP, Frijters JE, Defares PB (1986). Life events, emotional eating and change in body mass index. Int J Obes 10, 29-35. (Pubitemid 16107652)
41. Wong GT, Gannon KS, Margolskee RF (1996). Transduction of bitter and sweet taste by gustducin. Nature 381, 796-800. (Pubitemid 26243121)